Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Mulligan

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
World Journal of Clinical Cases|August 25, 2015
Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to dateKyle Crassini, Stephen P Mulligan, O Giles Best
Leukemia & Lymphoma|August 4, 2017
Recommendations for skin cancer monitoring for patients with chronic lymphocytic leukemiaAnthea Mulcahy, Stephen P Mulligan, Stephen P Shumack
Blood|June 23, 2009
Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL)Christopher S Mulligan, Miriam E Thomas, Stephen P Mulligan
Leukemia & Lymphoma|June 29, 2022
Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical managementCatherine Tang, Yandong Shen, Asha Soosapilla, et al.
Leukemia Research|May 26, 2004
Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycinPaul K Wilson, Stephen P Mulligan, Richard I Christopherson
The New England Journal of Medicine|November 7, 2008
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemiaChristopher S Mulligan, Miriam E Thomas, Stephen P Mulligan
Haematologica|July 5, 2018
Immune failure, infection and survival in chronic lymphocytic leukemiaKyle R Crassini, O Giles Best, Stephen P Mulligan
Current Opinion in Molecular Therapeutics|January 15, 2010
Membrane proteomics for leukemia classification and drug target identificationPhilippa L Kohnke, Stephen P Mulligan, Richard I Christopherson
The New England Journal of Medicine|June 12, 2009
The precursor of chronic lymphocytic leukemiaChristopher S Mulligan, O Giles Best, Stephen P Mulligan, et al.
Leukemia & Lymphoma|July 16, 2011
Monoclonal B-lymphocytosis: demographics, nature and subclassification in 414 community patientsChristopher S Mulligan, Miriam E Thomas, Stephen P Mulligan
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
World Journal of Clinical Cases|August 25, 2015
Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to dateKyle Crassini, Stephen P Mulligan, O Giles Best
Leukemia & Lymphoma|August 4, 2017
Recommendations for skin cancer monitoring for patients with chronic lymphocytic leukemiaAnthea Mulcahy, Stephen P Mulligan, Stephen P Shumack
Blood|June 23, 2009
Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL)Christopher S Mulligan, Miriam E Thomas, Stephen P Mulligan
Leukemia & Lymphoma|June 29, 2022
Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical managementCatherine Tang, Yandong Shen, Asha Soosapilla, et al.
Leukemia Research|May 26, 2004
Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycinPaul K Wilson, Stephen P Mulligan, Richard I Christopherson
The New England Journal of Medicine|November 7, 2008
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemiaChristopher S Mulligan, Miriam E Thomas, Stephen P Mulligan
Haematologica|July 5, 2018
Immune failure, infection and survival in chronic lymphocytic leukemiaKyle R Crassini, O Giles Best, Stephen P Mulligan
Current Opinion in Molecular Therapeutics|January 15, 2010
Membrane proteomics for leukemia classification and drug target identificationPhilippa L Kohnke, Stephen P Mulligan, Richard I Christopherson
The New England Journal of Medicine|June 12, 2009
The precursor of chronic lymphocytic leukemiaChristopher S Mulligan, O Giles Best, Stephen P Mulligan, et al.
Leukemia & Lymphoma|July 16, 2011
Monoclonal B-lymphocytosis: demographics, nature and subclassification in 414 community patientsChristopher S Mulligan, Miriam E Thomas, Stephen P Mulligan
Pageof 9